X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6547) 6547
Book Review (1468) 1468
Publication (624) 624
Book Chapter (74) 74
Conference Proceeding (11) 11
Dissertation (9) 9
Book / eBook (2) 2
Government Document (2) 2
Magazine Article (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5479) 5479
animals (3726) 3726
humans (3313) 3313
vascular-permeability (2890) 2890
endothelial growth-factor (2112) 2112
vascular-permeability factor (1882) 1882
male (1702) 1702
angiogenesis (1556) 1556
mice (1484) 1484
female (1410) 1410
vascular permeability (1306) 1306
rats (1110) 1110
vascular endothelial growth factor (1006) 1006
permeability (971) 971
oncology (838) 838
expression (832) 832
in-vivo (801) 801
pharmacology & pharmacy (768) 768
cell biology (735) 735
inflammation (676) 676
biochemistry & molecular biology (673) 673
vegf (672) 672
endothelium (604) 604
cancer (596) 596
capillary permeability - drug effects (591) 591
vascular endothelial growth factor a (591) 591
cells (587) 587
vascular endothelial growth factors (579) 579
cells, cultured (533) 533
physiology (499) 499
adult (473) 473
immunology (461) 461
disease models, animal (458) 458
vascular endothelial growth factor a - metabolism (457) 457
research (456) 456
middle aged (454) 454
capillary permeability (436) 436
time factors (435) 435
analysis (418) 418
medicine, research & experimental (405) 405
abridged index medicus (404) 404
rats, sprague-dawley (395) 395
peripheral vascular disease (391) 391
article (386) 386
endothelial cells (386) 386
ophthalmology (382) 382
proteins (380) 380
immunohistochemistry (373) 373
mice, inbred c57bl (360) 360
endothelium, vascular - metabolism (358) 358
neurosciences (358) 358
signal transduction (346) 346
physiological aspects (344) 344
aged (340) 340
tumor angiogenesis (338) 338
tumors (332) 332
in-vitro (326) 326
neovascularization (312) 312
endothelial-cells (309) 309
hematology (308) 308
endothelial cells - metabolism (302) 302
health aspects (300) 300
activation (299) 299
pathology (292) 292
growth-factor (288) 288
surgery (285) 285
phosphorylation (283) 283
capillary permeability - physiology (280) 280
rodents (279) 279
dose-response relationship, drug (277) 277
respiratory system (276) 276
rats, wistar (266) 266
tyrosine kinase (259) 259
endothelium, vascular - cytology (256) 256
receptor (254) 254
edema (253) 253
endothelium, vascular - drug effects (247) 247
inhibition (244) 244
cell line, tumor (238) 238
nitric-oxide (235) 235
neoplasms - drug therapy (234) 234
neovascularization, pathologic (233) 233
cardiac & cardiovascular systems (230) 230
metastasis (229) 229
hypoxia (227) 227
up-regulation (226) 226
mice, inbred balb c (224) 224
tumor-necrosis-factor (224) 224
multidisciplinary sciences (223) 223
cytokines (221) 221
medicine (221) 221
apoptosis (220) 220
care and treatment (219) 219
endocrinology & metabolism (219) 219
research article (216) 216
angiogenesis inhibitors - therapeutic use (215) 215
ve-cadherin (213) 213
nitric oxide (211) 211
gene expression (210) 210
nitric-oxide synthase (210) 210
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6472) 6472
Japanese (47) 47
German (32) 32
Chinese (22) 22
French (21) 21
Spanish (10) 10
Portuguese (3) 3
Czech (1) 1
Korean (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2010, Volume 107, Issue 6, pp. 2425 - 2430
Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel formation through activation of three receptor tyrosine kinases, VEGFR-1, -2, and... 
Proteins | Angiogenesis | Receptors | Vascular endothelial growth factors | Endothelial growth factors | Ligands | Dimers | Chimeras | Monomers | Crystal structure | Vascular endothelial growth factor receptor-2 | Lymphangiogenesis | Vascular endothelial growth factor C | ACTIVATION | COMPLEX | FACTOR-C | angiogenesis | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | ORF-VIRUS | TYROSINE KINASES | vascular endothelial growth factor receptor-2 | VASCULAR-PERMEABILITY | FAMILY-MEMBER | lymphangiogenesis | KINASE DOMAIN RECEPTOR | vascular endothelial growth factor C | Humans | Crystallography, X-Ray | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Recombinant Fusion Proteins - metabolism | Spodoptera | Vascular Endothelial Growth Factor Receptor-2 - genetics | Vascular Endothelial Growth Factor A - chemistry | Vascular Endothelial Growth Factor C - chemistry | Vascular Endothelial Growth Factor Receptor-1 - genetics | Protein Structure, Tertiary | Cell Line | Cell Survival | Models, Molecular | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Binding Sites - genetics | Recombinant Fusion Proteins - chemistry | Vascular Endothelial Growth Factor Receptor-3 - metabolism | Vascular Endothelial Growth Factor Receptor-1 - chemistry | Vascular Endothelial Growth Factor C - genetics | Vascular Endothelial Growth Factor Receptor-3 - chemistry | Vascular Endothelial Growth Factor Receptor-2 - chemistry | Animals | Hydrogen Bonding | Vascular Endothelial Growth Factor C - metabolism | Protein Binding | Recombinant Fusion Proteins - genetics | Protein Conformation | Kinetics | Mutation | Vascular Endothelial Growth Factor Receptor-3 - genetics | Development and progression | Research | Growth factor receptors | Neovascularization | Properties | Vascular endothelial growth factor | Protein binding | Lymphangioma | Signal transduction | Immunoglobulins | Membranes | Biochemistry | Kinases | Binding sites | Index Medicus | Biological Sciences
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 269 - 11
Resistance towards VEGF-centered anti-angiogenic therapy still represents a substantial clinical challenge. We report here that mast cells alter the... 
BREAST-CANCER | NEOADJUVANT CHEMOTHERAPY | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | IN-VIVO | C-KIT | EXTRACELLULAR-MATRIX | HEPARAN-SULFATE PROTEOGLYCANS | TUMOR ANGIOGENESIS | VASCULAR-PERMEABILITY | ENDOTHELIAL GROWTH-FACTOR | Fibroblast Growth Factor 2 - drug effects | Human Umbilical Vein Endothelial Cells | Granulocyte-Macrophage Colony-Stimulating Factor - metabolism | Granzymes - metabolism | Extracellular Matrix - metabolism | Vascular Endothelial Growth Factor A - metabolism | Fibroblast Growth Factor 1 - drug effects | Cromolyn Sodium - pharmacology | Fibroblast Growth Factor 2 - metabolism | Vascular Endothelial Growth Factor A - drug effects | Anti-Asthmatic Agents - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - drug effects | Endothelial Cells - metabolism | Extracellular Matrix - drug effects | Fibroblast Growth Factor 1 - metabolism | Angiogenesis Inhibitors - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Neoplasms - blood supply | Vitronectin - metabolism | Mast Cells - drug effects | Granulocyte-Macrophage Colony-Stimulating Factor - drug effects | Neoplasms - drug therapy | Animals | Cell Line, Tumor | Mast Cells - secretion | Cell Proliferation - drug effects | Mice | Neovascularization, Pathologic - metabolism | Laminin - metabolism | Endothelial Cells - drug effects | Fibroblast growth factor 2 | Therapy | Fibroblast growth factor | Fibroblast growth factor 1 | Granulocyte-macrophage colony-stimulating factor | Secretion | Endothelial cells | Histamine | Angiogenesis | Granzyme B | Antiangiogenics | Mast cells | Vascular endothelial growth factor | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, pp. e85311 - e85311
As neovascularization is essential for tumor growth and metastasis, controlling angiogenesis is a promising tactic in limiting cancer progression. Melatonin... 
IN-VITRO | SIGNALING PATHWAYS | STEM-CELLS | RAT GLIOMA | INHIBITION | MULTIDISCIPLINARY SCIENCES | PROLIFERATION | VASCULAR-PERMEABILITY | VEIN ENDOTHELIAL-CELLS | EXPRESSION | CARCINOMA | Neoplasm Transplantation | Receptor, Epidermal Growth Factor - genetics | Humans | Neovascularization, Pathologic | Ki-67 Antigen - metabolism | Transplantation, Heterologous | Insulin-Like Growth Factor I - genetics | Vascular Endothelial Growth Factor A - metabolism | von Willebrand Factor - genetics | Vascular Endothelial Growth Factor A - genetics | Vascular Endothelial Growth Factor Receptor-2 - genetics | Receptor, Epidermal Growth Factor - metabolism | Female | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | von Willebrand Factor - metabolism | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Antioxidants - pharmacology | Breast Neoplasms - blood supply | Breast Neoplasms - drug therapy | Animals | Breast Neoplasms - genetics | Ki-67 Antigen - genetics | Tumor Burden - drug effects | Breast Neoplasms - pathology | Mice, Nude | Mice | Melatonin - pharmacology | Insulin-Like Growth Factor I - metabolism | Immunohistochemistry | Melatonin | Growth | Von Willebrand factor | Breast cancer | SPECT imaging | Neovascularization | Vascular endothelial growth factor | Cell proliferation | Cell culture | Surgical implants | Laboratories | Technetium | Metastasis | Kinases | Vascularization | Metastases | Angiogenesis | Densitometers | Cell growth | Epidermal growth factor | Computed tomography | Rodents | Animal tissues | Xenografts | Densitometry | Growth factors | Photon emission | Insulin | Single photon emission computed tomography | Medical prognosis | Breast | Hypoxia | In vivo methods and tests | Cell size | Molecular biology | Viability | Tumors | Cancer | Index Medicus
Journal Article
Hypertension, ISSN 0194-911X, 08/2010, Volume 56, Issue 2, pp. 260 - 267
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 09/1998, Volume 188, Issue 6, pp. 1135 - 1145
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 01/2015, Volume 125, Issue 4, pp. 710 - 719
The precise mechanism for reduced thrombosis in prekallikrein null mice (Klkb1(-/-)) is unknown. Klkb1(-/-) mice have delayed carotid artery occlusion times on... 
PLASMA KALLIKREIN | MOLECULAR-WEIGHT KININOGEN | ENDOTHELIAL-CELLS | IN-VIVO | NITRIC-OXIDE | FACTOR EXPRESSION | VASCULAR-PERMEABILITY | DEFICIENT MICE | CONTACT ACTIVATION | HEMATOLOGY | FACTOR-XII | Epoprostenol - genetics | Receptor, Bradykinin B2 - genetics | Receptors, G-Protein-Coupled - metabolism | Epoprostenol - biosynthesis | Peptide Fragments - pharmacology | Carotid Artery Thrombosis - metabolism | Pyrones - pharmacology | Sirtuin 1 - genetics | Thromboplastin - antagonists & inhibitors | Nerve Tissue Proteins - biosynthesis | Synaptotagmins - biosynthesis | Carotid Artery Thrombosis - chemically induced | Prekallikrein | Thromboplastin - biosynthesis | Proto-Oncogene Proteins - metabolism | Kruppel-Like Transcription Factors - biosynthesis | Proto-Oncogene Proteins - antagonists & inhibitors | Angiotensin II - pharmacology | Receptor, Bradykinin B2 - biosynthesis | Sirtuin 1 - biosynthesis | Proto-Oncogene Proteins - genetics | Imidazoles - pharmacology | Angiotensin II - analogs & derivatives | Sulfonamides - pharmacology | Nerve Tissue Proteins - genetics | Sirtuin 1 - antagonists & inhibitors | Mice, Knockout | Naphthalenes - pharmacology | Animals | Partial Thromboplastin Time | Thromboplastin - genetics | Receptors, G-Protein-Coupled - antagonists & inhibitors | Mice | Receptors, G-Protein-Coupled - genetics | Synaptotagmins - genetics | Carotid Artery Thrombosis - genetics | Carotid Artery Thrombosis - pathology | Kruppel-Like Transcription Factors - antagonists & inhibitors | Kruppel-Like Transcription Factors - genetics | RNA, Messenger | Index Medicus | Abridged Index Medicus | Thrombosis and Hemostasis
Journal Article
The American Journal of Pathology, ISSN 0002-9440, 10/2017, Volume 187, Issue 10, pp. 2337 - 2347
Journal Article
American Journal of Physiology - Cell Physiology, ISSN 0363-6143, 09/2004, Volume 287, Issue 3, pp. 746 - 753
Hypoxia-induced physiological stress plays a central role in various neovascular diseases of the eye. Increased expression of hypoxia-inducible factor 1α... 
Angiogenesis | Hypoxia | Hypoxia-inducible factor 1 | Insulin-like growth factor binding protein | Vascular endothelial growth factor | hypoxia | PHYSIOLOGY | SUBFOVEAL FIBROVASCULAR MEMBRANES | angiogenesis | MACULAR DEGENERATION | FACTOR EXPRESSION | BINDING-PROTEINS | CELL BIOLOGY | FACTOR 1-ALPHA | vascular endothelial growth factor | hypoxia-inducible factor 1 | EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION | VASCULAR-PERMEABILITY FACTOR | EXTRACELLULAR-MATRIX | insulin-like growth factor binding protein | ENDOTHELIAL GROWTH-FACTOR | HYPOXIA-INDUCIBLE FACTOR-1 | Vascular Endothelial Growth Factor A - biosynthesis | Insulin-Like Growth Factor I - pharmacology | Pigment Epithelium of Eye - drug effects | Humans | Pigment Epithelium of Eye - physiology | Insulin-Like Growth Factor Binding Protein 3 - pharmacology | Recombinant Proteins - biosynthesis | Hypoxia-Inducible Factor 1, alpha Subunit | Transcription Factors - drug effects | Dose-Response Relationship, Drug | Cobalt - pharmacology | Time Factors | Vascular Endothelial Growth Factor A - drug effects | Vascular Endothelial Growth Factor A - pharmacology | Autocrine Communication - physiology | Gene Expression Regulation | Transcription Factors - biosynthesis | Recombinant Proteins - pharmacology | Blotting, Western | Choroidal Neovascularization - physiopathology | Insulin-Like Growth Factor Binding Protein 3 - biosynthesis | Recombinant Proteins - drug effects | Insulin-Like Growth Factor Binding Protein 3 - drug effects | Hypoxia - physiopathology | Insulin-Like Growth Factor I - metabolism | Index Medicus
Journal Article